Salud financiera de hoja de balance de Neuland Laboratories
Salud financiera controles de criterios 6/6
Neuland Laboratories tiene un patrimonio de accionistas total de ₹14.0B y una deuda total de ₹941.5M, lo que sitúa su ratio deuda-patrimonio en 6.7%. Sus activos y pasivos totales son ₹19.4B y ₹5.5B respectivamente. El BAIT de Neuland Laboratories es de ₹3.5B, por lo que su ratio de cobertura de intereses es de -5315.1. Tiene efectivo e inversiones a corto plazo que ascienden a ₹1.9B.
Información clave
6.7%
Ratio deuda-patrimonio
₹941.46m
Deuda
| Ratio de cobertura de intereses | -5315.1x |
| Efectivo | ₹1.90b |
| Patrimonio | ₹13.95b |
| Total pasivo | ₹5.49b |
| Activos totales | ₹19.44b |
Actualizaciones recientes sobre salud financiera
Is Neuland Laboratories (NSE:NEULANDLAB) Using Too Much Debt?
Jun 12
Neuland Laboratories (NSE:NEULANDLAB) Seems To Use Debt Rather Sparingly
Jan 05Neuland Laboratories (NSE:NEULANDLAB) Seems To Use Debt Rather Sparingly
Aug 24Here's Why Neuland Laboratories (NSE:NEULANDLAB) Can Manage Its Debt Responsibly
Aug 30Recent updates
Concerns Surrounding Neuland Laboratories' (NSE:NEULANDLAB) Performance
Nov 14Neuland Laboratories Limited Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected
Nov 09Here's Why We Think Neuland Laboratories (NSE:NEULANDLAB) Is Well Worth Watching
Nov 08After Leaping 27% Neuland Laboratories Limited (NSE:NEULANDLAB) Shares Are Not Flying Under The Radar
Oct 17Neuland Laboratories Limited's (NSE:NEULANDLAB) Shares Climb 44% But Its Business Is Yet to Catch Up
Aug 22Is Now The Time To Put Neuland Laboratories (NSE:NEULANDLAB) On Your Watchlist?
Aug 02Neuland Laboratories' (NSE:NEULANDLAB) Dividend Will Be Increased To ₹14.00
Jul 12Optimistic Investors Push Neuland Laboratories Limited (NSE:NEULANDLAB) Shares Up 28% But Growth Is Lacking
Jul 02Neuland Laboratories' (NSE:NEULANDLAB) Upcoming Dividend Will Be Larger Than Last Year's
Jun 19Is Neuland Laboratories (NSE:NEULANDLAB) Using Too Much Debt?
Jun 12Neuland Laboratories (NSE:NEULANDLAB) Will Pay A Larger Dividend Than Last Year At ₹14.00
May 21There's Reason For Concern Over Neuland Laboratories Limited's (NSE:NEULANDLAB) Massive 25% Price Jump
Apr 19We Ran A Stock Scan For Earnings Growth And Neuland Laboratories (NSE:NEULANDLAB) Passed With Ease
Apr 15Subdued Growth No Barrier To Neuland Laboratories Limited (NSE:NEULANDLAB) With Shares Advancing 29%
Feb 17Revenue Beat: Neuland Laboratories Limited Exceeded Revenue Forecasts By 8.1% And Analysts Are Updating Their Estimates
Feb 12Neuland Laboratories (NSE:NEULANDLAB) Seems To Use Debt Rather Sparingly
Jan 05The Neuland Laboratories Limited (NSE:NEULANDLAB) Analyst Just Boosted Their Forecasts By A Meaningful Amount
Nov 12Here's Why We Think Neuland Laboratories (NSE:NEULANDLAB) Might Deserve Your Attention Today
Oct 27Neuland Laboratories (NSE:NEULANDLAB) Seems To Use Debt Rather Sparingly
Aug 24Forecast: Analysts Think Neuland Laboratories Limited's (NSE:NEULANDLAB) Business Prospects Have Improved Drastically
Aug 05Neuland Laboratories (NSE:NEULANDLAB) Is Increasing Its Dividend To ₹10.00
Jul 05Neuland Laboratories (NSE:NEULANDLAB) Is Increasing Its Dividend To ₹10.00
Jun 21Neuland Laboratories (NSE:NEULANDLAB) Is Increasing Its Dividend To ₹10.00
May 14Should You Be Adding Neuland Laboratories (NSE:NEULANDLAB) To Your Watchlist Today?
May 12Here's Why Neuland Laboratories (NSE:NEULANDLAB) Can Manage Its Debt Responsibly
Aug 30I Built A List Of Growing Companies And Neuland Laboratories (NSE:NEULANDLAB) Made The Cut
Feb 23The Consensus EPS Estimates For Neuland Laboratories Limited (NSE:NEULANDLAB) Just Fell Dramatically
Feb 03Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo (₹9.7B) de NEULANDLAB superan a sus pasivos a corto plazo (₹4.1B).
Pasivo a largo plazo: Los activos a corto plazo de NEULANDLAB (₹9.7B) superan a sus pasivos a largo plazo (₹1.4B).
Historial y análisis de deuda-patrimonio
Nivel de deuda: NEULANDLAB tiene más efectivo que su deuda total.
Reducción de la deuda: El ratio deuda-patrimonio de NEULANDLAB ha pasado de 28.1% a 6.7% en los últimos 5 años.
Cobertura de la deuda: La deuda de NEULANDLAB está bien cubierta por el flujo de caja operativo (261%).
Cobertura de intereses: NEULANDLAB gana más intereses de los que paga, por lo que la cobertura de pagos de intereses no es preocupante.